Kathleen S. Capps

CIK: 0002085127

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (50.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ENTA

ENANTA PHARMACEUTICALS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (4 total)

ENTA
ENANTA PHARMACEUTICALS INC
Dec 5, 2025
Sale(S)
Direct
323 shares at avg. $14.23$5K
ENTA
ENANTA PHARMACEUTICALS INC
Dec 2, 2025
Sale(S)
Direct
207 shares at avg. $13.96$3K
ENTA
ENANTA PHARMACEUTICALS INC
Dec 1, 2025
Tax Payment(F)
Direct
85 shares at avg. $14.12$1K
ENTA
ENANTA PHARMACEUTICALS INC
Nov 25, 2025
Award(A)
Direct
3.2K shares-

		Type	Shares	Price		Ownership
Dec 5, 2025	ENTA ENANTA PHARMACEUTICALS INC	Sale(S)	323	$14.23	$4,596	Direct
Dec 2, 2025	ENTA ENANTA PHARMACEUTICALS INC	Sale(S)	207	$13.96	$2,890	Direct
Dec 1, 2025	ENTA ENANTA PHARMACEUTICALS INC	Tax Payment(F)	85	$14.12	$1,200	Direct
Nov 25, 2025	ENTA ENANTA PHARMACEUTICALS INC	Award(A)	3,163	-	-	Direct

1-4 of 4 transactions

About Capps Kathleen S.

Capps Kathleen S. (SEC CIK 0002085127) files insider reports with the SEC as Officer of ENANTA PHARMACEUTICALS INC (ENTA).

Signal8 holds 4 ownership filings by Capps Kathleen S. (1 Form 3, 3 Form 4), filed between Sep 8, 2025 and Dec 5, 2025. Those filings report 4 transactions, from Nov 25, 2025 to Dec 5, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Capps Kathleen S.'s filings is in WATERTOWN, MA.

Recent filings by Capps Kathleen S.

Dec 5, 2025: Open-market sale of ENTA shares (Form 4, code S).
Dec 2, 2025: Open-market sale of ENTA shares (Form 4, code S).
Dec 1, 2025: Tax withholding of ENTA shares (Form 4, code F).
Nov 25, 2025: Grant or award of ENTA shares (Form 4, code A).

Other insiders filing for ENANTA PHARMACEUTICALS INC (ENTA)

Rottinghaus Scott T., Chief Medical Officer
Vance Terry, Director
Russell Lesley, Director
Peterson Kristine, Director
Hata Yujiro S, Director
FOLETTA MARK G, Director

How to read Form 4 transaction codes